XML 21 R6.htm IDEA: XBRL DOCUMENT v3.24.1.u1Close
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash flows from operating activities    
Net income $ 839 $ 6,435
Adjustments to reconcile net income to net cash provided by operating activities:    
Unrealized foreign currency exchange loss (gain), net 3 (2)
Depreciation and amortization expense 302 297
Share-based compensation expense 40 49
Amortization of discount and debt issuance costs 10 12
Reduction of right-of-use assets 163 161
Gain on modification or extinguishment of debt 0 (20)
Total losses (gains) on derivative instruments, net 258 (4,641)
Net cash provided by (used for) settlement of derivative instruments 24 (31)
Deferred taxes (6) 1,232
Other, net 2 1
Changes in operating assets and liabilities:    
Trade and other receivables 430 1,016
Inventory 81 361
Margin deposits (17) 71
Other current assets, net 14 31
Accounts payable and accrued liabilities (714) (1,277)
Total deferred revenue (42) (126)
Total operating lease liabilities (148) (154)
Other, net 7 6
Net cash provided by operating activities 1,246 3,421 Close
Cash flows from investing activities    
Property, plant and equipment, net (650) (712)
Investment in equity method investments (3) (10)
Other, net (13) (5)
Net cash used in investing activities (666) (727) Close
Cash flows from financing activities    
Proceeds from issuances of debt 1,497 0
Redemptions, repayments and repurchases of debt (150) (896)
Distributions to non-controlling interest (253) (261)
Payments related to tax withholdings for share-based compensation (40) (55)
Repurchase of common stock (1,189) (450)
Dividends to stockholders (105) (99)
Other, net (24) 21
Net cash used in financing activities (264) (1,740) Close
Effect of exchange rate changes on cash, cash equivalents and restricted cash and cash equivalents (3) 2 Close
Net increase in cash, cash equivalents and restricted cash and cash equivalents 313 956 Close
Cash, cash equivalents and restricted cash and cash equivalents—beginning of period 4,525 2,487
Cash, cash equivalents and restricted cash and cash equivalents—end of period $ 4,838 $ 3,443